Stay updated with breaking news from Single Pills. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-Ad-hoc: APONTIS PHARMA AG / Key word: Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year 2023 02-May-2023 / 21:50 CET/CEST Disclosure of an inside information... | May 2, 2023
02.05.2023 - EQS-Ad-hoc: APONTIS PHARMA AG / Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year 2023 02-May-2023 / 21:50 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No ...
APONTIS PHARMA AG / Key word(s): Forecast/Change in ForecastAPONTIS PHARMA AG adjusts forecast for fiscal year 202302-May-2023 / 21:50 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.The issuer is solely respon...
EQS-News: APONTIS PHARMA AG / Key word: Product Launch APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property... | April 12, 2023
EQS-News: APONTIS PHARMA AG / Key word(s): Product LaunchAPONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential 12.04.2023 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announceme...